Ann: Mesoblast Phase 3 Chronic Low Back Pain Results, page-151

That's not how I read it at all, I read it that over the full duration of the study they do not achieve a statistically significant result.

At 24 months, THE PRIMARY END POINT:Treatment Success (composite responder analysis of low back pain Visual Analogue Scale (VAS) score, Oswestry Disability Index (ODI) score and no post-treatment interventions) [ Time Frame: 24 Months ]• To determine Overall Treatment Success of rexlemestrocel-L alone or rexlemestrocel-L+HA through 24 months based on a composite responder analysis

They achieved a significant result reduction in pain:


I feel like I'm taking crazy pills lol

@LeftYahoo am I totally missing something.